# Dose Ranging Study of SPL7013 Gel for Treatment of Bacterial Vaginosis (BV)

> **NCT01201057** · PHASE2 · COMPLETED · sponsor: **Starpharma Pty Ltd** · enrollment: 132 (actual)

## Conditions studied

- Bacterial Vaginosis

## Interventions

- **DRUG:** 0.5% SPL7013 Gel
- **DRUG:** 1.0% SPL7013 Gel
- **DRUG:** 3.0% SPL7013 Gel
- **OTHER:** Placebo Gel

## Key facts

- **NCT ID:** NCT01201057
- **Lead sponsor:** Starpharma Pty Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-08
- **Primary completion:** 2011-03
- **Final completion:** 2011-05
- **Target enrollment:** 132 (ACTUAL)
- **Last updated:** 2019-06-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01201057

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01201057, "Dose Ranging Study of SPL7013 Gel for Treatment of Bacterial Vaginosis (BV)". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01201057. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*